Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Coeliac disease-associated polymorphisms influence thymic gene expression.
S S Amundsen1, M K Viken2, L M Sollid1
1Centre for Immune Regulation, Institute of Immunology, University of Oslo, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Coeliac disease (CD) genetic risk factors may influence T-cell development in the thymus. Our study found CD-associated single nucleotide polymorphisms (SNPs) with regulatory potential in thymic tissue, suggesting a novel role in CD pathogenesis.
Area of Science:
- Immunogenetics
- Molecular Biology
- Human Genetics
Background:
- Coeliac disease (CD) is associated with numerous genetic risk regions, primarily containing non-coding single nucleotide polymorphisms (SNPs).
- Previous expression quantitative trait loci (eQTL) analysis identified cis-regulatory potential for some CD-associated SNPs in peripheral blood mononuclear cells (PBMC).
- Many CD-associated regions harbor genes involved in immunological pathways, including T-cell development, which has not been extensively studied in CD pathogenesis.
Purpose of the Study:
- To investigate the regulatory potential of 50 CD-associated SNPs in thymic tissue using eQTL analysis.
- To explore the role of T-cell development pathways in CD pathogenesis.
- To identify novel thymus-specific regulatory mechanisms influenced by CD risk polymorphisms.
Main Methods:
- eQTL analysis was performed on thymic tissue samples from 42 subjects.
- Fifty CD-associated SNPs were analyzed for their association with gene expression in the thymus.
- Results were compared with existing eQTL data from PBMC and other tissues.
Main Results:
- 43 nominally significant eQTLs were identified within 24 CD-associated chromosomal regions.
- These eQTLs involved 27 expression-altering SNPs (eSNPs) and 39 unique genes (eGenes).
- Nine significant probe-SNP pairs overlapped with previous PBMC findings, while 14 eQTLs suggested potential thymus-specific regulation.
Conclusions:
- CD-associated SNPs demonstrate cis-regulatory potential within thymic tissue.
- These findings implicate T-cell development in the thymus as a potentially relevant pathway in CD pathogenesis.
- CD risk polymorphisms may exert their effects through gene regulation in the thymus, highlighting a novel aspect of CD genetics.
More Related Videos
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Inflammatory Bowel Disease III: Crohn's Disease
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters